{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:46:38Z","timestamp":1761864398203,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cardfail.2025.05.012","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T23:05:32Z","timestamp":1748041532000},"page":"1037-1038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Sarcoidosis: A Target of Rapamycin?"],"prefix":"10.1016","volume":"31","author":[{"given":"DANIEL","family":"SYKORA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-0233","authenticated-orcid":false,"given":"ANDREW","family":"ROSENBAUM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2025.05.012_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02695-2020","article-title":"Phagosome-regulated mTOR signalling during sarcoidosis granuloma biogenesis","volume":"57","author":"Crouser","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0003","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0004","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","article-title":"Sarcoidosis and the mTOR, Rac1, and autophagy triad","volume":"41","author":"Pacheco","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00430-2019","article-title":"Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis","volume":"54","author":"Calender","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030478","article-title":"An mTORC1-dependent mouse model for cardiac sarcoidosis","volume":"12","author":"Bueno-Beti","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0008","article-title":"Utility of mechanistic target of rapamycin inhibitors in cardiac sarcoidosis","author":"Richards","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0009","first-page":"2008","article-title":"Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC: Cardiovasc Imag"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCGEN.123.004099","article-title":"Cardiac sarcoidosis mimickers: genetic testing in undifferentiated inflammatory cardiomyopathies","volume":"16","author":"Castrichini","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0011","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3389\/fimmu.2018.02181","article-title":"Early everolimus initiation fails to counteract the cytotoxic response mediated by CD8+ T and NK cells in heart transplant patients","volume":"9","author":"D\u00edaz-Molina","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.cardfail.2025.05.012_bib0012","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425002374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425002374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T09:37:08Z","timestamp":1751967428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1071916425002374"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.05.012","relation":{},"ISSN":["1071-9164"],"issn-type":[{"type":"print","value":"1071-9164"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Sarcoidosis: A Target of Rapamycin?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.10.444","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}